{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "WebPage",
      "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#WebPage",
      "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
      "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors",
      "isPartOf": {
        "@type": "WebSite",
        "@id": "https://iddi.com#WebSite",
        "url": "https://iddi.com",
        "name": "IDDI"
      }
    },
    {
      "@type": "BreadcrumbList",
      "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#BreadcrumbList",
      "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
      "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors",
      "itemListElement": [
        {
          "@type": "ListItem",
          "@id": "https://iddi.com/resources#BreadCrumbList_Item",
          "url": "https://iddi.com/resources",
          "item": "https://iddi.com/resources",
          "name": "Resources",
          "position": 1
        },
        {
          "@type": "ListItem",
          "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#BreadCrumbList_Item",
          "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
          "item": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
          "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors",
          "position": 2
        }
      ]
    },
    {
      "@type": "WebSite",
      "@id": "https://iddi.com#WebSite",
      "url": "https://iddi.com",
      "name": "IDDI"
    },
    {
      "@type": "Organization",
      "@id": "https://iddi.com#Organization",
      "url": "https://iddi.com",
      "name": "IDDI",
      "logo": {
        "@type": "ImageObject",
        "@id": "https://iddi.com#ImageObjectLogo",
        "url": "https://mva.org/wp-content/uploads/2020/01/iddi-logo.png",
        "contentUrl": "https://mva.org/wp-content/uploads/2020/01/iddi-logo.png",
        "name": "IDDI Logo",
        "caption": "IDDI Logo"
      },
      "sameAs": [
        "https://www.linkedin.com/company/iddi",
        "https://twitter.com/IDDI_Official",
        "https://www.facebook.com/profile.php?id=100052568724769",
        "https://www.youtube.com/channel/UC4Ef4_yf5Wurco-2YiVguqg"
      ]
    },
    {
      "@type": "Brand",
      "@id": "https://iddi.com#Brand",
      "url": "https://iddi.com",
      "name": "IDDI",
      "sameAs": [
        "https://www.linkedin.com/company/iddi",
        "https://twitter.com/IDDI_Official",
        "https://www.facebook.com/profile.php?id=100052568724769",
        "https://www.youtube.com/channel/UC4Ef4_yf5Wurco-2YiVguqg"
      ]
    },
    {
      "@type": "AggregateRating",
      "@id": "https://iddi.com#AggregateRating",
      "url": "https://iddi.com",
      "name": "IDDI",
      "ratingValue": 1,
      "ratingCount": 1,
      "itemReviewed": {
        "@type": "Organization",
        "@id": "https://iddi.com#Organization"
      }
    },
    {
      "@type": "Article",
      "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#Article",
      "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
      "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors",
      "headline": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors",
      "isPartOf": {
        "@type": "Collection",
        "@id": "https://iddi.com/resources#Collection",
        "url": "https://iddi.com/resources",
        "name": "IDDI Resources"
      }
    }
  ]
}